Cellid Co., Ltd. Logo

Cellid Co., Ltd.

Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.

299660 | KO

Overview

Corporate Details

ISIN(s):
KR7299660001
LEI:
Country:
South Korea
Address:
서울시 관악구 관악로 1 서울대학교 142동 5층, 서울시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cellid Co., Ltd. is a research and development-focused biotechnology company specializing in immunotherapeutic vaccines for cancer and infectious diseases. The company's core business is centered on its proprietary technology platforms. Its key offering, CeliVax, is an anti-cancer immunotherapeutic vaccine platform that utilizes a patient's own B cells and monocytes, designed to be applicable to any cancer with identified antigens. In addition, Cellid has developed an adenovirus vector-based platform for creating preventive vaccines against infectious diseases, notably used in the development of a COVID-19 vaccine. The company's pipeline is focused on leveraging these technologies to address significant unmet medical needs in oncology and virology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(일정금액이상의청구)
Korean 8.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1015.8 KB
2025-08-12 00:00
Legal Proceedings Report
소송등의판결ㆍ결정(일정금액이상의청구)
Korean 7.0 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 28.4 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 25.5 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 25.5 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 25.5 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 27.6 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 26.2 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 27.6 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 26.2 KB
2025-06-30 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-06-30 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-06-30 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-06-30 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB

Automate Your Workflow. Get a real-time feed of all Cellid Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cellid Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cellid Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HANALL BIOPHARMA CO.,LTD Logo
Develops innovative medicines for chronic diseases through antibody and small molecule research.
South Korea
009420
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea
293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea
128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden
HNSA
Harmony Biosciences Holdings, Inc. Logo
Develops innovative therapies for rare neurological diseases, focusing on conditions like narcolepsy.
United States of America
HRMY
HARROW, INC. Logo
Develops branded ophthalmic therapies and custom compounded solutions for North American eyecare.
United States of America
HROW
HCW Biologics Inc. Logo
Developing novel immunotherapies to treat aging-related chronic inflammation.
United States of America
HCWB
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan
4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan
219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom
HELD

Talk to a Data Expert

Have a question? We'll get back to you promptly.